TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 10
1.1 OVERVIEW 10
2 MARKET INTRODUCTION 11
2.1 DEFINITION 11
2.2 SCOPE OF THE STUDY 11
2.3 RESEARCH OBJECTIVE 11
2.4 MARKET STRUCTURE 12
2.5 ASSUMPTIONS & LIMITATIONS 12
3 RESEARCH METHODOLOGY 13
3.1 DATA MINING 13
3.2 SECONDARY RESEARCH 14
3.3 PRIMARY RESEARCH 14
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 15
3.5 FORECASTING TECHNIQUES 16
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 17
3.6.1 BOTTOM-UP APPROACH 17
3.6.2 TOP-DOWN APPROACH 18
3.7 DATA TRIANGULATION 18
3.8 VALIDATION 18
4 MARKET DYNAMICS 19
4.1 OVERVIEW 19
4.2 DRIVERS 20
4.2.1 INCREASING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES 20
4.2.2 GROWING MEDICAL TOURISM INDUSTRY 20
4.2.3 INCREASING USE OF NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES 21
4.3 RESTRAINTS 22
4.3.1 SIDE-EFFECTS ASSOCIATED WITH AESTHETIC PROCEDURES 22
4.4 OPPORTUNITY 23
4.4.1 RAPID TECHNOLOGICAL ADVANCEMENT IS CREATING LUCRATIVE OPPORTUNITIES 23
5 MARKET FACTOR ANALYSIS 25
5.1 VALUE CHAIN ANALYSIS 25
5.1.1 R&D 26
5.1.2 MANUFACTURING 26
5.1.3 DISTRIBUTION & SALES 26
5.1.4 POST-SALES MONITORING 26
5.2 PORTER’S FIVE FORCES MODEL 27
5.2.1 THREAT OF NEW ENTRANTS 27
5.2.2 BARGAINING POWER OF SUPPLIERS 28
5.2.3 THREAT OF SUBSTITUTES 28
5.2.4 BARGAINING POWER OF BUYERS 28
5.2.5 INTENSITY OF RIVALRY 28
5.3 IMPACT OF COVID-19 ON THE THAILAND MEDICAL AESTHETICS MARKET 29
5.3.1 IMPACT ON SUPPLY CHAIN 29
5.3.2 IMPACT ON PATIENTS SUFFERING FROM AESTHETIC PROBLEM 29
5.3.3 IMPACT ON DEMAND 29
6 THAILAND MEDICAL AESTHETICS MARKET, BY PRODUCT 30
6.1 OVERVIEW 30
7 THAILAND MEDICAL AESTHETICS MARKET, BY TECHNOLOGY 37
7.1 OVERVIEW 37
8 THAILAND MEDICAL AESTHETICS MARKET, BY END USER 41
8.1 OVERVIEW 41
9.1 OVERVIEW 44
9.2 COMPETITIVE BENCHMARKING 45
9.3 MAJOR GROWTH STRATEGY IN THE THAILAND MEDICAL AESTHETICS MARKET 46
9.4 MAJOR PLAYERS FINANCIAL MATRIX 46
9.4.1 SALES (USD MILLION), 2022 46
9.4.2 R&D (USD MILLION), 2022 47
10 COMPANY PROFILES 48
10.1 JOHNSON & JOHNSON SERVICES, INC 48
10.1.1 COMPANY OVERVIEW 48
10.1.2 FINANCIAL OVERVIEW 49
10.1.3 PRODUCTS OFFERED 50
10.1.4 KEY DEVELOPMENTS 50
10.1.5 SWOT ANALYSIS 51
10.1.6 KEY STRATEGIES 51
10.2 VENUS CONCEPT 52
10.2.1 COMPANY OVERVIEW 52
10.2.2 FINANCIAL OVERVIEW 53
10.2.3 PRODUCTS OFFERED 54
10.2.4 KEY DEVELOPMENTS 54
10.2.5 SWOT ANALYSIS 55
10.2.6 KEY STRATEGIES 55
10.3 CYNOSURE 56
10.3.1 COMPANY OVERVIEWS 56
10.3.2 FINANCIAL OVERVIEW 56
10.3.3 PRODUCTS OFFERED 56
10.3.4 KEY DEVELOPMENTS 57
10.3.5 KEY STRATEGIES 57
10.4 CANDELA CORPORATION 58
10.4.1 COMPANY OVERVIEW 58
10.4.2 FINANCIAL OVERVIEW 58
10.4.3 PRODUCTS OFFERED 58
10.4.4 KEY DEVELOPMENTS 59
10.4.5 KEY STRATEGIES 59
10.5 MEDYTOX 60
10.5.1 COMPANY OVERVIEW 60
10.5.2 FINANCIAL OVERVIEW 60
10.5.3 PRODUCTS OFFERED 60
10.5.4 KEY DEVELOPMENTS 60
10.5.5 KEY STRATEGIES 60
10.6 ZIMMER BIOMET 61
10.6.1 COMPANY OVERVIEW 61
10.6.2 FINANCIAL ANALYSIS 62
10.6.3 PRODUCTS OFFERED 62
10.6.4 KEY DEVELOPMENTS 63
10.6.5 SWOT ANALYSIS 63
10.6.6 KEY STRATEGIES 63
10.7 ALLERGAN PLC 64
10.7.1 COMPANY OVERVIEW 64
10.7.2 FINANCIAL OVERVIEW 64
10.7.3 PRODUCTS OFFERED 64
10.7.4 KEY DEVELOPMENTS 65
10.7.5 SWOT ANALYSIS 66
10.7.6 KEY STRATEGIES 66
10.8 MERZ PHARMA 67
10.8.1 COMPANY OVERVIEW 67
10.8.2 FINANCIAL OVERVIEW 67
10.8.3 PRODUCT OFFERED 67
10.8.4 KEY DEVELOPMENTS 68
10.8.5 KEY STRATEGIES 68
10.9 GALDERMA 69
10.9.1 COMPANY OVERVIEW 69
10.9.2 FINANCIAL OVERVIEW 69
10.9.3 PRODUCTS OFFERED 69
10.9.4 KEY DEVELOPMENTS 70
10.9.5 SWOT ANALYSIS 70
10.9.6 KEY STRATEGIES 70
10.10 SINCLAIR PHARMA 71
10.10.1 COMPANY OVERVIEW 71
10.10.2 FINANCIAL OVERVIEW 71
10.10.3 PRODUCTS OFFERED 71
10.10.4 KEY DEVELOPMENTS 72
10.10.5 KEY STRATEGIES 72
11 APPENDIX 73
11.1 REFERENCES 73
11.2 RELATED REPORTS 73
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 12
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 15
TABLE 3 THAILAND MEDICAL AESTHETICS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 32
TABLE 4 THAILAND MEDICAL AESTHETICS MARKET, FOR FACIAL AESTHETICS, BY TYPE, 2019-2030 (USD MILLION) 33
TABLE 5 THAILAND MEDICAL AESTHETICS MARKET, FOR BODY CONTOURING DEVICES, BY TYPE, 2019-2030 (USD MILLION) 34
TABLE 6 THAILAND MEDICAL AESTHETICS MARKET, FOR COSMETIC IMPLANTS, BY TYPE, 2019-2030 (USD MILLION) 35
TABLE 7 THAILAND MEDICAL AESTHETICS MARKET, FOR SKIN AESTHETIC DEVICES, BY TYPE, 2019-2030 (USD MILLION) 36
TABLE 8 TOTAL SURGICAL PROCEDURES, 2021 37
TABLE 9 TOTAL NON-SURGICAL PROCEDURES, 202 38
TABLE 10 THAILAND MEDICAL AESTHETICS MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION) 40
TABLE 11 THAILAND MEDICAL AESTHETICS MARKET, BY END USER, 2019-2030 (USD MILLION) 43
TABLE 12 MAJOR PLAYERS IN THE THAILAND MEDICAL AESTHETICS MARKET 44
TABLE 13 JOHNSON & JOHNSON SERVICES, INC: PRODUCTS OFFERED 50
TABLE 14 JOHNSON & JOHNSON SERVICES, INC: KEY DEVELOPMENTS 50
TABLE 15 VENUS CONCEPT: PRODUCTS OFFERED 54
TABLE 16 VENUS CONCEPT: KEY DEVELOPMENTS 54
TABLE 17 CYNOSURE: PRODUCTS OFFERED 56
TABLE 18 CYNOSURE: KEY DEVELOPMENTS 57
TABLE 19 CANDELA CORPORATION: PRODUCTS OFFERED 58
TABLE 20 CANDELA CORPORATION: KEY DEVELOPMENTS 59
TABLE 21 MEDYTOX: PRODUCTS OFFERED 60
TABLE 22 ZIMMER BIOMET: PRODUCTS OFFERED 62
TABLE 23 ALLERGAN PLC: PRODUCTS OFFERED 64
TABLE 24 ALLERGAN PLC: KEY DEVELOPMENTS 65
TABLE 25 MERZ PHARMA: PRODUCT OFFERED 67
TABLE 26 MERZ PHARMA: KEY DEVELOPMENTS 68
TABLE 27 GALDERMA: PRODUCTS OFFERED 69
TABLE 28 GALDERMA: KEY DEVELOPMENTS 70
TABLE 29 SINCLAIR PHARMA: PRODUCTS OFFERED 71
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
